We are thrilled to announce that our 14th Annual Appendix Cancer PMP Virtual Walk/Run raised over $90,000 for appendix cancer research and education which is truly incredible. We more than doubled the amount raised at last year's event, thanks to our amazing and generous supporters! Thank you, thank you, thank you!!! We had supporters from all across the US, Canada...

FDA has now approved KEYTRUDA (pembrolizumab) for a second indication based on a tumor biomarker rather than the originating source of the tumor in the body.  Specifically, FDA has approved KEYTRUDA for patients with an unresectable or metastatic solid tumor with a high mutational burden (i.e, 10 or more mutations).  As part of this approval, FDA has also approved Foundation...

We hope you will join us this Father's Day Weekend (June 20th and 21st) for our 14th Annual Appendix Cancer/PMP VIRTUAL Walk/Run! This is our first 100% VIRTUAL walk/run and that means you can participate from ANYWHERE IN THE WORLD! Register to walk, run, hike, bike -- whatever you choose, or make a donation and be entered into the raffle for an...